Download Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Proteomics Market: By Technology By Component, By Application, By End-Users and Region Forecast 2021-2032
Proteomics Market: By Technology By Component, By Application, By End-Users and Region Forecast 2021-2032
Report ID:16780
Published Date:Aug 2025
No of Pages:222
Format:
Proteomics Market size was valued at US$ 26,412.6 million in 2025 and is expected to reach US$ 60,239.1 million by 2032, growing at a significant CAGR of 12.5% from 2026-2032.
Proteomics is a technique for identifying and studying proteins implicated in diseases, as well as their expression, activity, and structure. Proteomic research may also be utilized to find prognostic indicators and diagnose cancer, infectious illnesses, malaria, and TB. In the pharmaceutical sector, proteomics is utilized to examine the mechanism of medication action or toxicity. Based on the technology protein microarray segment generated the highest revenue in 2021 in the market, owing to the technology being widely used to track protein interactions in less time than other technologies. Furthermore, this procedure requires less time and is cost-effective. The entire information about DNA/RNA binding proteins can be made available with the use of a protein microarray.
Moreover, based on components, the reagents segment accounted for the majority of market share, it is attributed to the availability of a wide range of reagents and the need for reliable, specific, and fast detection of diseases at the early stages as they are extensively utilized in primary screening in drug discovery and microarray technologies. Increasing demand for factors like rising demand for personalized medicine, increasing R&D expenditure, government funding for proteomics, and technological advancements driving the market growth over the forecast years.
Study Period
2026-2032Base Year
2025CAGR
12.5%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
The market is expected to offer lucrative opportunities due to increase research and development programs and increase biotech expenditure attributing to coronavirus driving the global proteomic market growth. Moreover, due to technological advancement, increase in research funding, growing healthcare spending, demand for customized medicine, and rise in the prevalence of genetic diseases also immense boost to the market over the forecast years.
North America has the largest share in the global proteomics market and the market is expected to grow at a significant CAGR over the forecast years owing to increasing investments in personalized medicine, the existence of global market leaders, increased research in the disciplines of omics, and increased investments in structure-based drug design.
Asia Pacific is also likely to show significant growth over the forecasting period owing to a rise in prevalence of genetic disease, an increase in R&D expenditure, and expansion of business by the market players into the region.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2026-2032 |
|
Market CAGR |
12.5% |
|
By Technology |
|
|
By Component |
|
|
By Application |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
Proteomics Market size was valued at US$ 26,412.6 million in 2025 and is expected to reach US$ 60,239.1 million by 2032, growing at a significant CAGR of 12.5% from 2026-2032.
Thermo Fisher Scientific, Agilent Technologies, Bruker Corporation, Bio-Rad Laboratories, PerkinElmer
The Asia Pacific is the fastest-growing region for the market
The proteomics market is driven by the rising prevalence of chronic and infectious diseases, increasing demand for advanced diagnostic solutions, and growing applications in personalized medicine. Advancements in bioinformatics tools, rising investments in drug discovery, and the expansion of clinical trials market growth
Content Updated Date: Feb 2026
| 1. Executive Summary |
| 2. Global Proteomics Market Introduction |
| 2.1.Global Proteomics Market - Taxonomy |
| 2.2.Global Proteomics Market - Definitions |
| 2.2.1.Technology |
| 2.2.2.Component |
| 2.2.3.Application |
| 2.2.4.Region |
| 3. Global Proteomics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Proteomics Market Analysis, 2021-2025 and Forecast 2026-2032 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Proteomics Market By Technology, 2021-2025 and Forecast 2026-2032 (Sales Value USD Million) |
| 5.1. Protein Microarrays |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Spectroscopy |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. X-ray Crystallography |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Chromatography |
| 5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Electrophoresis |
| 5.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Surface Plasmon Resonance |
| 5.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6. Global Proteomics Market By Component, 2021-2025 and Forecast 2026-2032 (Sales Value USD Million) |
| 6.1. Reagents & Kits |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Instruments |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Software & Services |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Global Proteomics Market By Application, 2021-2025 and Forecast 2026-2032 (Sales Value USD Million) |
| 7.1. Research Applications |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Clinical Applications |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 8. Global Proteomics Market By Region, 2021-2025 and Forecast 2026-2032 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. North America Proteomics Market ,2021-2025 and Forecast 2026-2032 (Sales Value USD Million) |
| 9.1. Technology Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Protein Microarrays |
| 9.1.2.Spectroscopy |
| 9.1.3.X-ray Crystallography |
| 9.1.4.Chromatography |
| 9.1.5.Electrophoresis |
| 9.1.6.Surface Plasmon Resonance |
| 9.2. Component Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Reagents & Kits |
| 9.2.2.Instruments |
| 9.2.3.Software & Services |
| 9.3. Application Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Research Applications |
| 9.3.2.Clinical Applications |
| 9.4. Country Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10. Europe Proteomics Market ,2021-2025 and Forecast 2026-2032 (Sales Value USD Million) |
| 10.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Protein Microarrays |
| 10.1.2.Spectroscopy |
| 10.1.3.X-ray Crystallography |
| 10.1.4.Chromatography |
| 10.1.5.Electrophoresis |
| 10.1.6.Surface Plasmon Resonance |
| 10.2. Component Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Reagents & Kits |
| 10.2.2.Instruments |
| 10.2.3.Software & Services |
| 10.3. Application Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Research Applications |
| 10.3.2.Clinical Applications |
| 10.4. Country Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 10.4.7. |
| 11. Asia Pacific (APAC) Proteomics Market ,2021-2025 and Forecast 2026-2032 (Sales Value USD Million) |
| 11.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Protein Microarrays |
| 11.1.2.Spectroscopy |
| 11.1.3.X-ray Crystallography |
| 11.1.4.Chromatography |
| 11.1.5.Electrophoresis |
| 11.1.6.Surface Plasmon Resonance |
| 11.2. Component Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Reagents & Kits |
| 11.2.2.Instruments |
| 11.2.3.Software & Services |
| 11.3. Application Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Research Applications |
| 11.3.2.Clinical Applications |
| 11.4. Country Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12. Middle East and Africa (MEA) Proteomics Market ,2021-2025 and Forecast 2026-2032 (Sales Value USD Million) |
| 12.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Protein Microarrays |
| 12.1.2.Spectroscopy |
| 12.1.3.X-ray Crystallography |
| 12.1.4.Chromatography |
| 12.1.5.Electrophoresis |
| 12.1.6.Surface Plasmon Resonance |
| 12.2. Component Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Reagents & Kits |
| 12.2.2.Instruments |
| 12.2.3.Software & Services |
| 12.3. Application Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Research Applications |
| 12.3.2.Clinical Applications |
| 12.4. Country Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13. Latin America Proteomics Market ,2021-2025 and Forecast 2026-2032 (Sales Value USD Million) |
| 13.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Protein Microarrays |
| 13.1.2.Spectroscopy |
| 13.1.3.X-ray Crystallography |
| 13.1.4.Chromatography |
| 13.1.5.Electrophoresis |
| 13.1.6.Surface Plasmon Resonance |
| 13.2. Component Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Reagents & Kits |
| 13.2.2.Instruments |
| 13.2.3.Software & Services |
| 13.3. Application Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Research Applications |
| 13.3.2.Clinical Applications |
| 13.4. Country Analysis 2021-2025 and Forecast 2026-2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Agilent Technologies, Inc. |
| 14.2.2.Bio-Rad Laboratories, Inc. |
| 14.2.3.Bruker Corporation |
| 14.2.4.Danaher Corporation |
| 14.2.5.GE Healthcare |
| 14.2.6.Merck KGaA |
| 14.2.7.Promega Corporation |
| 14.2.8.Thermo Fisher Scientific, Inc. |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.